CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Restricted Cash, Current
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Restricted Cash, Current of $24.43 million as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2026-08-05
- 2026-06-27: Restricted Cash, Current $24.43M.
- 2026-03-28: Restricted Cash, Current $1.93M.
- 2025-12-27: Restricted Cash, Current $666.00K.
- 2025-09-27: Restricted Cash, Current $573.00K.
| Period end | Restricted Cash, Current |
|---|---|
| 2026-06-27 | $24.43M 10-Q · filed 2026-08-05 |
| 2026-03-28 | $1.93M 10-Q · filed 2026-05-07 |
| 2025-12-27 | $666.00K 10-K · filed 2026-02-18 |
| 2025-09-27 | $573.00K 10-Q · filed 2025-11-05 |
| 2025-06-28 | $398.00K 10-Q · filed 2026-08-05 |
| 2025-03-29 | $904.00K 10-Q · filed 2026-05-07 |
| 2024-12-28 | $9.54M 10-K · filed 2026-02-18 |
| 2024-09-28 | $323.00K 10-Q · filed 2025-11-05 |
| 2024-06-29 | $325.00K 10-Q · filed 2025-08-06 |
| 2024-03-30 | $10.33M 10-Q · filed 2025-05-07 |
| 2023-12-30 | $5.80M 10-K · filed 2025-02-19 |
| 2023-09-30 | $6.59M 10-Q · filed 2024-11-06 |
| 2023-07-01 | $7.14M 10-Q · filed 2023-08-09 |
| 2023-04-01 | $6.16M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $6.19M 10-K · filed 2024-02-14 |
| 2022-09-24 | $1.38M 10-Q · filed 2022-11-02 |
| 2022-06-25 | $5.80M 10-Q · filed 2022-08-03 |
| 2022-03-26 | $413.00K 10-Q · filed 2023-05-11 |
| 2021-09-25 | $4.28M 10-Q · filed 2022-11-02 |
| 2021-06-26 | $3.12M 10-Q · filed 2022-08-03 |
| 2021-03-27 | $4.01M 10-Q · filed 2022-05-04 |
| 2020-12-26 | $3.07M 10-Q · filed 2021-11-03 |
| 2020-09-26 | $2.97M 10-Q · filed 2021-11-03 |
| 2020-06-27 | $465.00K 10-Q · filed 2021-08-04 |
| 2020-03-28 | $444.00K 10-Q · filed 2021-05-04 |
| 2019-12-28 | $431.00K 10-Q · filed 2020-10-29 |
| 2019-09-28 | $534.00K 10-Q · filed 2020-10-29 |
| 2019-06-29 | $498.00K 10-Q · filed 2020-08-05 |
| 2019-03-30 | $491.00K 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |